Use of solid phase extraction (SPE) to evaluate in vitro skin permeation of aescin

Pharmazie

Volumn 62, Issue 5, 2007, Pages 342-345

  Montenegro, Lucia ^a   Carbone, C ^a   Giannone, I ^a   Puglisi, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESCIN;

ACCURACY; ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DIFFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; REPRODUCIBILITY; SKIN ABSORPTION; SOLID PHASE EXTRACTION;

ADULT; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA INTERPRETATION, STATISTICAL; DIFFUSION CHAMBERS, CULTURE; ESCIN; GELS; HUMANS; PHARMACEUTICAL SOLUTIONS; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; SKIN; SKIN ABSORPTION; SOLID PHASE EXTRACTION;

EID: 34249798696     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.5.6178     Document Type: Article

References (18)

1. Apers S, Naessens T, Pieters L, Vlietinck A (2006) Densitometric thin-layer chromatographic determination of aescin in a herbal medicinal product containing Aesculus and Vitis dry extracts. L Chromatogr A 1112: 165-170.
2. Barry BW (1993) Vehicle effect: what is an enhancer? In Shah VP, Maibach HI (eds.) Topical drug bioavailability, bioequivalence, and penetration. New York p. 261-276.
3. Bonina FP, Montenegro L (1992) Penetration enhancer effects on in vitro percutaneous absorption of heparin sodium salt. Int J Pharm 82: 171-177.
4. Bonina FP, Montenegro L (1994) Vehicle effects on in vitro heparin release and skin permeation from different gels. Int J Pharm 102: 19-24.
5. Bronaugh RL, Stewart RF (1985) Methods for in vitro percutaneous absorption studies: IV. The flow-through diffusion cell. J Pharm Sci 74: 64-67.
6. Bronaugh RL, Stewart RF, Congdon ER (1982) Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 62: 481-488.
7. Cross SE, Jiang R, Benson HAE, Roberts M (2001) Can increasing the viscosity of formulations be used to reduce the human skin penetration of the sunscreen oxybenzone? J Invest Dermatol 117: 147-150.
8. Flynn GL, Yalkowsky SH, Roseman TJ (1974) Mass transport phenomena and models: theoretical concepts. J Pharm Sci 63: 479-510.
9. Fritz JS, Dumont PJ, Schmidt LW (1995) Methods and materials for solid phase extraction. L Chromatogr A 691: 133-140.
10. Kligman AM, Christophers E (1963) Preparation of isolated sheets of human skin. Arch Dermatol 88: 702-705.
11. Kockar OM, Kara M, Kara S, Bozan B, Baser KHC (1994) Quantitative determination of escin. A comparative study of HPLC and TLC-densitometry. Fitoterapia 65: 439-443.
12. Lang W (1977) Percutaneous absorption of escin-3H in mice and rats. Arzneim-Forsch 24: 71-76.
13. Panigati D (1992) Pharmacology of escin, a saponin from Aesculus hippocastanum L. Part II. Pharmacology of escin. Chapter I Boll Chim Farm 131: 242-246.
14. Pietta P, Mauri P, Facino RM, Carini M (1989) High performance liquid chromatographic analysis of β-escin. J Chromatogr 478: 259-263.
15. Przerwa M, Arnold M, (1975) Penetrability of the skin. Arzneim-Forsch 25: 1048-1053.
16. Rothkopf M, Vogel G (1976) New findings on the efficacy and mode of action of the horse chestnut saponin escin. Arzneim-Forsch 26: 225-235.
17. Smith RM (2003) Before the injection - Modern methods of sample preparation for separation techniques. J Chromatogr A 1000: 3-27.
18. Vogel G, Marek ML, Oertner R (1970) Studies on the mechanism of the therapeutic and toxic action of the horse chestnut saponin aescin. Arzneim-Forsch 20: 699-703.